{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:21:10Z","timestamp":1790824870074,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier","isbn-type":[{"value":"9780128234686","type":"print"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.enz.2021.07.001","type":"book-chapter","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T09:41:43Z","timestamp":1634895703000},"page":"39-62","source":"Crossref","is-referenced-by-count":25,"title":["Mechanisms of inhibition of viral RNA replication by nucleotide analogs"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.enz.2021.07.001_bb0010","doi-asserted-by":"crossref","first-page":"10112","DOI":"10.1074\/jbc.RA120.013422","article-title":"Resistance to excision determines efficiency of hepatitis C virus RNA-dependent RNA polymerase inhibition by nucleotide analogs","volume":"295","author":"Villalba","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2021.07.001_bb0015","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.molcel.2021.01.035","article-title":"Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication","volume":"81","author":"Bravo","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/bs.enz.2021.07.001_bb0020","doi-asserted-by":"crossref","first-page":"101849","DOI":"10.1016\/j.isci.2020.101849","article-title":"Remdesivir is effective in combating COVID-19 because it is a better substrate than ATP for the viral RNA-dependent RNA polymerase","volume":"23","author":"Dangerfield","year":"2020","journal-title":"iScience"},{"key":"10.1016\/bs.enz.2021.07.001_bb0025","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","article-title":"Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2021.07.001_bb0030","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1038\/s41467-020-18463-z","article-title":"Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis","volume":"11","author":"Shannon","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/bs.enz.2021.07.001_bb0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0166-3542(95)00836-5","article-title":"Mechanisms for the anti-hepatitis B virus activity and mitochondrial toxicity of fialuridine (FIAU)","volume":"29","author":"Colacino","year":"1996","journal-title":"Antiviral Res."},{"key":"10.1016\/bs.enz.2021.07.001_bb0040","doi-asserted-by":"crossref","first-page":"40847","DOI":"10.1074\/jbc.M106743200","article-title":"Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase","volume":"276","author":"Johnson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2021.07.001_bb0045","doi-asserted-by":"crossref","first-page":"14711","DOI":"10.1021\/bi035596s","article-title":"Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase","volume":"42","author":"Lee","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/bs.enz.2021.07.001_bb0050","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1021\/bi200204m","article-title":"Role of induced fit in limiting discrimination against AZT by HIV reverse transcriptase","volume":"50","author":"Kellinger","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/bs.enz.2021.07.001_bb9000","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1128\/AAC.44.1.217-221.2000","article-title":"Mechanism of inhibition of the human immunodeficiency virus type 1 reverse transcriptase by d4TTP: an equivalent incorporation efficiency relative to the natural substrate dTTP","volume":"44","author":"Vaccaro","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/bs.enz.2021.07.001_bb0055","doi-asserted-by":"crossref","first-page":"7734","DOI":"10.1073\/pnas.0913946107","article-title":"Nucleotide-dependent conformational change governs specificity and analog discrimination by HIV reverse transcriptase","volume":"107","author":"Kellinger","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.enz.2021.07.001_bb9005","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1096\/fasebj.13.12.1511","article-title":"Mechanistic studies show that (-)-FTC-TP is a better inhibitor of HIV-1 reverse transcriptase than 3TC-TP","volume":"13","author":"Feng","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/bs.enz.2021.07.001_bb0060","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.1021\/bi034435l","article-title":"Probing the molecular mechanisms of AZT drug resistance mediated by HIV-1 reverse transcriptase using a transient kinetic analysis","volume":"42","author":"Ray","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/bs.enz.2021.07.001_bb9030","doi-asserted-by":"crossref","first-page":"27250","DOI":"10.1074\/jbc.273.42.27250","article-title":"Selective inhibition of HIV-1 reverse transcriptase by an antiviral inhibitor, (R)-9-(2-Phosphonylmethoxypropyl)adenine","volume":"273","author":"Suo","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2021.07.001_bb0065","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev.bi.62.070193.003345","article-title":"Conformational coupling in DNA polymerase fidelity","volume":"62","author":"Johnson","year":"1993","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/bs.enz.2021.07.001_bb0070","doi-asserted-by":"crossref","first-page":"25988","DOI":"10.1016\/S0021-9258(18)35706-5","article-title":"Mechanism and fidelity of HIV reverse transcriptase","volume":"267","author":"Kati","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2021.07.001_bb0075","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/bi00216a029","article-title":"Pre-steady-state kinetic-analysis of processive DNA-replication including complete characterization of an exonuclease-deficient mutant","volume":"30","author":"Patel","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/bs.enz.2021.07.001_bb0080","doi-asserted-by":"crossref","first-page":"100143","DOI":"10.1074\/jbc.RA120.016617","article-title":"Conformational dynamics during high fidelity DNA replication and translocation defined using a DNA polymerase with a fluorescent artificial amino acid","volume":"296","author":"Dangerfield","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2021.07.001_bb0085","doi-asserted-by":"crossref","first-page":"9675","DOI":"10.1021\/bi060993z","article-title":"A new paradigm for DNA polymerase specificity","volume":"45","author":"Tsai","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/bs.enz.2021.07.001_bb0090","series-title":"Kinetic Analysis for the New Enzymology: Using Computer Simulation to Learn Kinetics and Solve Mechanisms","author":"Johnson","year":"2019"},{"key":"10.1016\/bs.enz.2021.07.001_bb0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1097-2765(00)80185-9","article-title":"A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase","volume":"4","author":"Meyer","year":"1999","journal-title":"Mol. Cell."},{"key":"10.1016\/bs.enz.2021.07.001_bb0100","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nm0897-922","article-title":"The bottleneck in AZT activation","volume":"3","author":"Lavie","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/bs.enz.2021.07.001_bb0105","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nsb0897-601","article-title":"Structure of thymidylate kinase reveals the cause behind the limiting step in AZT activation","volume":"4","author":"Lavie","year":"1997","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/bs.enz.2021.07.001_bb0110","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2174\/0929867325666181001105749","article-title":"Cordycepin in anticancer research: molecular mechanism of therapeutic effects","volume":"27","author":"Khan","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/bs.enz.2021.07.001_bb0115","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s40265-020-01378-w","article-title":"Remdesivir: first approval","volume":"80","author":"Lamb","year":"2020","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/bs.enz.2021.07.001_bb0120","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00162-20","article-title":"Remdesivir against COVID-19 and other viral diseases","volume":"34","author":"Malin","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/bs.enz.2021.07.001_bb0125","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 days in patients with severe Covid-19","volume":"383","author":"Goldman","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.enz.2021.07.001_bb0130","doi-asserted-by":"crossref","first-page":"104899","DOI":"10.1016\/j.phrs.2020.104899","article-title":"Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: clinical outcome and differences in post-treatment hospitalisation status","volume":"158","author":"Antinori","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/bs.enz.2021.07.001_bb0135","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.abc1560","article-title":"Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir","volume":"368","author":"Yin","year":"2020","journal-title":"Science"},{"key":"10.1016\/bs.enz.2021.07.001_bb0140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-020-2368-8","article-title":"Structure of replicating SARS-CoV-2 polymerase","volume":"584","author":"Hillen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/bs.enz.2021.07.001_bb0145","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41467-020-20542-0","article-title":"Mechanism of SARS-CoV-2 polymerase stalling by remdesivir","volume":"12","author":"Kokic","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/bs.enz.2021.07.001_bb0150","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2020.05.034","article-title":"Structural basis for RNA replication by the SARS-CoV-2 polymerase","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/bs.enz.2021.07.001_bb0155","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2020.11.016","article-title":"Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex reveals an intermediate state in cap synthesis","volume":"184","author":"Yan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/bs.enz.2021.07.001_bb0160","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.1073\/pnas.1718806115","article-title":"Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA","volume":"115","author":"Ferron","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.enz.2021.07.001_bb0165","doi-asserted-by":"crossref","first-page":"9436","DOI":"10.1073\/pnas.1508686112","article-title":"Structural basis and functional analysis of the SARS coronavirus nsp14\u2013nsp10 complex","volume":"112","author":"Ma","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/bs.enz.2021.07.001_bb0170","doi-asserted-by":"crossref","first-page":"114239","DOI":"10.1016\/j.ab.2021.114239","article-title":"High throughput quantification of short nucleic acid samples by capillary electrophoresis with automated data processing","volume":"629","author":"Dangerfield","year":"2021","journal-title":"Anal. Biochem."},{"key":"10.1016\/bs.enz.2021.07.001_bb0175","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ab.2008.12.025","article-title":"FitSpace explorer: an algorithm to evaluate multidimensional parameter space in fitting kinetic data","volume":"387","author":"Johnson","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/bs.enz.2021.07.001_bb0180","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ab.2008.12.024","article-title":"Global Kinetic Explorer: a new computer program for dynamic simulation and fitting of kinetic data","volume":"387","author":"Johnson","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/bs.enz.2021.07.001_bb0185","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1021\/acs.jpclett.0c00571","article-title":"Novel coronavirus polymerase and nucleotidyl-transferase structures: potential to target new outbreaks","volume":"11","author":"Zhang","year":"2020","journal-title":"J. Phys. Chem. Lett."},{"issue":"6664","key":"10.1016\/bs.enz.2021.07.001_bb0190","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/34593","article-title":"Crystal structure of a bacteriophage T7 DNA replication complex at 2.2 A resolution","volume":"391","author":"Doublie","year":"1998","journal-title":"Nature"},{"key":"10.1016\/bs.enz.2021.07.001_bb0195","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.282.5394.1669","article-title":"Structure of a covalently trapped catalytic complex of HIV-I reverse transcriptase: Implications for drug resistance","volume":"282","author":"Huang","year":"1998","journal-title":"Science"},{"key":"10.1016\/bs.enz.2021.07.001_bb0200","doi-asserted-by":"crossref","first-page":"104793","DOI":"10.1016\/j.antiviral.2020.104793","article-title":"Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 exonuclease active-sites","volume":"178","author":"Shannon","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/bs.enz.2021.07.001_bb0205","doi-asserted-by":"crossref","first-page":"16156","DOI":"10.1074\/jbc.AC120.015720","article-title":"Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action","volume":"295","author":"Tchesnokov","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2021.07.001_bb0210","series-title":"Signatures and Mechanisms of Efficacious Therapeutic Ribonucleotides Against SARSCoV-2 Revealed by Analysis of Its Replicase Using Magnetic Tweezers","author":"Seifert","year":"2020"},{"key":"10.1016\/bs.enz.2021.07.001_bb0215","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1021\/bi00216a031","article-title":"Kinetic partitioning between the exonuclease and polymerase sites in DNA error correction","volume":"30","author":"Donlin","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/bs.enz.2021.07.001_bb0220","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00221-18","article-title":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease","volume":"9","author":"Agostini","year":"2018","journal-title":"MBio"},{"key":"10.1016\/bs.enz.2021.07.001_bb0225","doi-asserted-by":"crossref","first-page":"42097","DOI":"10.1074\/jbc.M206725200","article-title":"The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using alpha-boranophosphate nucleotide analogues","volume":"277","author":"Deval","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2021.07.001_bb0230","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/j.ddtec.2012.09.003","article-title":"Practical considerations for developing nucleoside reverse transcriptase inhibitors","volume":"9","author":"Hurwitz","year":"2012","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/bs.enz.2021.07.001_bb0235","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12967-020-02355-3","article-title":"SARS-CoV-2 RNA polymerase as target for antiviral therapy","volume":"18","author":"Buonaguro","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/bs.enz.2021.07.001_bb0240","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41586-018-0238-4","article-title":"A naturally occurring antiviral ribonucleotide encoded by the human genome","volume":"558","author":"Gizzi","year":"2018","journal-title":"Nature"}],"container-title":["The Enzymes","Viral Replication Enzymes and their Inhibitors Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604721000111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604721000111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:17:34Z","timestamp":1753888654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874604721000111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780128234686"],"references-count":50,"URL":"https:\/\/doi.org\/10.1016\/bs.enz.2021.07.001","relation":{},"ISSN":["1874-6047"],"issn-type":[{"value":"1874-6047","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}